EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The role of biomarkers in the early detection of pancreatic cancer

Michael Goggins

Familial Cancer · 2024-08 · 23 (3) · 309-322

DOI: 10.1007/s10689-024-00381-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Familial Cancer, online erschienen am 25.04.2024. Verfasst von Michael Goggins. Beteiligte Einrichtung: Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, 1550 Orleans Street, Bal…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Early Detection of Cancer, Biomarkers, Tumor. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Stand Up To Cancer, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic surveillance can detect early-stage pancreatic cancer and achieve long-term survival, but currently involves annual endoscopic ultrasound and MRI/MRCP, and is recommended only for individuals who meet familial/genetic risk criteria. To improve upon current approaches to pancreatic cancer early detection and to expand access, more accurate, inexpensive, and safe biomarkers are needed, but finding them has remained elusive. Newer approaches to early detection, such as using gene tests to personalize biomarker interpretation, and the increasing application of artificial intelligence approaches to integrate complex biomarker data, offer promise that clinically useful biomarkers for early pancreatic cancer detection are on the horizon.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsEarly Detection of CancerBiomarkers, TumorHumans

Stichwörter der Autor:innen

BiomarkerCA19-9Early detectionFamilial pancreatic cancerIntraductal papillary mucinous neoplasmPancreatic cancerPancreatic cystPancreatic intraepithelial neoplasiaPancreatic surveillanceTumor marker gene test

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, 1550 Orleans Street, Baltimore, MD, 21231, USA. mgoggins@jhmi.edu.
  • Department of Medicine, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. mgoggins@jhmi.edu.
  • Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. mgoggins@jhmi.edu.

Förderung

  • NCI NIH HHS
  • Stand Up To Cancer
  • National Cancer Institute

Zitieren

APA

Goggins, M. (2024). The role of biomarkers in the early detection of pancreatic cancer. Familial Cancer, 23(3), 309-322. https://doi.org/10.1007/s10689-024-00381-4

Vancouver

Goggins M. The role of biomarkers in the early detection of pancreatic cancer. Familial Cancer. 2024;23(3):309-322. doi:10.1007/s10689-024-00381-4

BibTeX
@article{Goggins2024,
  author = {Goggins, Michael},
  title = {The role of biomarkers in the early detection of pancreatic cancer},
  journal = {Familial Cancer},
  year = {2024},
  volume = {23},
  number = {3},
  pages = {309--322},
  doi = {10.1007/s10689-024-00381-4}
}
Kostenlos starten →